B, N., M, I., R, C., PJ, K., & KB, S. (2025). Navigating the Development of Dry Powder for Inhalation: A CDMO Perspective. Pharmaceuticals (Basel, Switzerland), 18(3), . https://doi.org/10.3390/ph18030434
Chicago Style (17th ed.) CitationB, Noriega-Fernandes, Ibrahim M, Cruz R, Kuehl PJ, and Shepard KB. "Navigating the Development of Dry Powder for Inhalation: A CDMO Perspective." Pharmaceuticals (Basel, Switzerland) 18, no. 3 (2025). https://doi.org/10.3390/ph18030434.
MLA (9th ed.) CitationB, Noriega-Fernandes, et al. "Navigating the Development of Dry Powder for Inhalation: A CDMO Perspective." Pharmaceuticals (Basel, Switzerland), vol. 18, no. 3, 2025, https://doi.org/10.3390/ph18030434.
Warning: These citations may not always be 100% accurate.